Life Sciences
Decoding Antibody Discovery—The Future of Next-Gen Biologics
This GEN webinar, our subject matter experts, Dr. Christian Olsen and Dr. Nimesh Joseph from Dotmatics, will provide an overview of current trends in monoclonal…
Broadcast Date: December 13, 2022
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Antibodies have established themselves as one of the most important classes within the biologics space, and developing these therapeutics requires a series of successful decisions throughout the early-discovery process. Antibody discovery is a complex and often circuitous route, which, if not efficiently optimized, can cost investigators valuable time and money. In this GEN webinar, our subject matter experts, Dr. Christian Olsen and Dr. Nimesh Joseph, will provide an overview of current trends in monoclonal antibody research and discovery and how science and technology are converging to create cutting-edge workflows designed to drive innovation and breakthroughs in the largest biologics therapeutic class today.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.
Produced with support from:
Biology Segment Leader
Dotmatics
Senior Solution Engineer
Dotmatics
The post Decoding Antibody Discovery—The Future of Next-Gen Biologics appeared first on GEN – Genetic Engineering and Biotechnology News.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
